REQUEST A DEMO
Total
USD $0.00
Search more companies

Talkmed Group Limited (Singapore)

Main Activities: Hospitals
Full name: Talkmed Group Limited Profile Updated: November 01, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Talkmed Group Limited is engaged in providing medical oncology and palliative care health care services. The company offers specialty services for patients with breast cancers, head and neck cancers, gastro-intestinal cancers, uro-gynaecological cancers, and haematology malignancies. Talkmed Group Limited is based in Singapore. The company was incorporated in 2013.

Legal Address
3 Mounth Elizabeth,#13-16/17,Mounth Elizabeth Hospital
Singapore; Singapore; Postal Code: 228510

Contact Details: Purchase the Talkmed Group Limited report to view the information.

Basic Information
Total Employees:
Purchase the Talkmed Group Limited report to view the information.
Outstanding Shares:
Purchase the Talkmed Group Limited report to view the information.
Financial Auditors:
Purchase the Talkmed Group Limited report to view the information.
Incorporation Date:
2013
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Operating Officer
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Ownership Details
Purchase this report to view the information.
5.28%
Company Performance
Financial values in the chart are available after Talkmed Group Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
5.86%
Total operating revenue
7.99%
Operating profit (EBIT)
-21.06%
EBITDA
-10.35%
Net Profit (Loss) for the Period
-24.67%
Total assets
44.04%
Total equity
33.46%
Operating Profit Margin (ROS)
-13.39%
Net Profit Margin
-12.33%
Return on Equity (ROE)
-12.42%
Debt to Equity Ratio
7.86%
Quick Ratio
-1.14%
Cash Ratio
-0.98%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?